Patient
P2B-120
completed Phase IIA Multicenter, Randomized, Open-Label Phase 2b Study to Investigate the Preliminary Efficacy and Safety of INNO-206 (Doxorubicin-EMCH) Compared to Doxorubicin in Subjects With Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcoma · University of Iowa (Iowa City, IA) (Dr. Okafor)
consented 2013-06-02
Adverse events
5
Serious AEs
0
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 5
Grade 2 decreased appetite with onset in cycle 5 (2013-09-20); assessed as not related to study drug (not related); resolved 2013-10-09.
Grade 1 alopecia with onset in cycle 3 (2013-08-04); assessed as related to study drug (probable); not resolved at last follow-up.
Grade 1 hypocalcaemia with onset in cycle 1 (2013-06-22); assessed as not related to study drug (not related); resolved 2013-07-02.
Grade 1 cough with onset in cycle 1 (2013-06-17); assessed as not related to study drug (unlikely); resolved 2013-07-06.
Grade 3 hypokalaemia with onset in cycle 1 (2013-06-13); assessed as not related to study drug (not related); resolved 2013-06-23.
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.